CLAVENTIN 5 g/200 mg, powder for solution for injection (i.v.) bottle, 5.81 g
Active ingredients: Clavulanic acid, Clavulanate potassium, Ticarcillin, Ticarcillin disodium
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder for solution for injectionbottle, 5.81 gintraveineuse
Out of stock
Package details
Original BDPM fields are shown in French.
- Official name
- CLAVENTIN 5 g/200 mg, poudre pour solution injectable (I.V.)
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 5,81 g
- Marketing authorisation holder
- LABORATOIRES DELBERT
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Aug 2007
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67557120CIP73769913CIP133400937699136Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TICARCILLINE BASEpoudre | 5,000 g · un flacon de 5,810 g | FT |
| TICARCILLINE SODIQUEpoudre | 5,572 g · un flacon de 5,810 g | SA |
| POTASSIUM (CLAVULANATE DE)poudre | 0,238 g · un flacon de 5,810 g | SA |
| ACIDE CLAVULANIQUEpoudre | 0,200 g · un flacon de 5,810 g | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.